Ajanta Pharma promoter Ravi Agrawal releases pledge on 1.6 lakh shares

Pledge ReleasedOwnership Changes View source PDF Explain this filing

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.3%Reaction day

₹3423.00

prior close

₹3340.40

announcement price

In-mkt

timing

Nifty Midcap 150market+0.2%-2.5% vs market

Pharmaceuticals peers, median of 165sector-0.0%-2.3% vs sector

On the reaction day the stock moved 2.5 pts less than Nifty Midcap 150 and 2.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.0

15m

+0.2

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.3+0.2-2.5-0.0-2.3

Next day

-2.4+0.7-3.1+0.1-2.5

-2.5+0.5-2.9+0.5-2.9

-1.4+0.9-2.3+0.1-1.5

-3.2+0.6-3.8-0.4-2.8

-4.1-1.0-3.0-1.2-2.9

-1.7+1.7-3.4+0.0-1.7

15d

+0.8+0.7+0.2-1.4+2.3

+2.6+2.8-0.3-1.2+3.8

+2.3+2.1+0.2+0.9+1.4

+4.8-5.0+9.7+0.0+4.7

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ravi Agrawal, trustee of Ravi Agrawal Trust and promoter of Ajanta Pharma, released a pledge on 1,60,000 equity shares (0.13 percent of total share capital) on June 30, 2026. The reason stated is excess pledge. Post-release, his pledged shares stand at 15.37 lakh (1.23 percent). The pledge was with Infina Finance for business financing.

Likely market impact

Release of excess pledge is a mildly positive signal, suggesting the promoter is reducing encumbrance and freeing up collateral on holdings.